Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Molecular classification of melanoma using real-time quantitative reverse transcriptase-polymerase chain reaction.

Lewis TB, Robison JE, Bastien R, Milash B, Boucher K, Samlowski WE, Leachman SA, Dirk Noyes R, Wittwer CT, Perreard L, Bernard PS.

Cancer. 2005 Oct 15;104(8):1678-86.

2.

Systematic search for the best gene expression markers for melanoma micrometastasis detection.

Soikkeli J, Lukk M, Nummela P, Virolainen S, Jahkola T, Katainen R, Harju L, Ukkonen E, Saksela O, Hölttä E.

J Pathol. 2007 Oct;213(2):180-9.

PMID:
17891747
3.

Pathologic assessment of melanoma sentinel nodes: a role for molecular analysis using quantitative real-time reverse transcription-PCR for MART-1 and tyrosinase messenger RNA.

Abrahamsen HN, Sorensen BS, Nexo E, Hamilton-Dutoit SJ, Larsen J, Steiniche T.

Clin Cancer Res. 2005 Feb 15;11(4):1425-33.

4.

Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay.

Włodzimierz R, Rutkowski P, Nowecki ZI, Kulik J, Nasierowska-Guttmejer A, Siedlecki JA.

Ann Surg Oncol. 2004 Nov;11(11):988-97. Epub 2004 Oct 15.

PMID:
15525828
5.

Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue.

Koh SS, Opel ML, Wei JP, Yau K, Shah R, Gorre ME, Whitman E, Shitabata PK, Tao Y, Cochran AJ, Abrishami P, Binder SW.

Mod Pathol. 2009 Apr;22(4):538-46. doi: 10.1038/modpathol.2009.8. Epub 2009 Mar 6.

6.

Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase-polymerase chain reaction for tyrosinase in melanoma patients.

Mangas C, Hilari JM, Paradelo C, Rex J, Fernández-Figueras MT, Fraile M, Alastrue A, Ferrándiz C.

Ann Surg Oncol. 2006 Jul;13(7):910-8. Epub 2006 May 22.

PMID:
16788751
7.

Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases.

Koh SS, Wei JP, Li X, Huang RR, Doan NB, Scolyer RA, Cochran AJ, Binder SW.

Mod Pathol. 2012 Jun;25(6):828-37. doi: 10.1038/modpathol.2012.32. Epub 2012 Mar 9.

8.

Detection of melanoma cells in sentinel lymph nodes by reverse transcriptase-polymerase chain reaction: prognostic significance.

Gradilone A, Ribuffo D, Silvestri I, Cigna E, Gazzaniga P, Nofroni I, Zamolo G, Frati L, Scuderi N, Aglianò AM.

Ann Surg Oncol. 2004 Nov;11(11):983-7. Epub 2004 Oct 15.

PMID:
15525827
9.

Novel genes associated with malignant melanoma but not benign melanocytic lesions.

Talantov D, Mazumder A, Yu JX, Briggs T, Jiang Y, Backus J, Atkins D, Wang Y.

Clin Cancer Res. 2005 Oct 15;11(20):7234-42.

10.

Expression of tyrosinase, MIA and MART-1 in sentinel lymph nodes of patients with malignant melanoma.

Hochberg M, Lotem M, Gimon Z, Shiloni E, Enk CD.

Br J Dermatol. 2002 Feb;146(2):244-9.

PMID:
11903234
11.

Expression analysis of genes identified by molecular profiling of VGP melanomas and MGP melanoma-positive lymph nodes.

McDonald SL, Edington HD, Kirkwood JM, Becker D.

Cancer Biol Ther. 2004 Jan;3(1):110-20. Epub 2004 Jan 24.

PMID:
14726712
12.

Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.

Nowecki ZI, Rutkowski P, Kulik J, Siedlecki JA, Ruka W.

Br J Dermatol. 2008 Sep;159(3):597-605. doi: 10.1111/j.1365-2133.2008.08710.x. Epub 2008 Jul 4.

PMID:
18616789
13.

Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma.

Matsuura K, Yamaguchi Y, Ueno H, Osaki A, Arihiro K, Toge T.

Cancer. 2006 Mar 15;106(6):1227-36.

14.

Detection of nonmelanoma skin cancer micrometastases in lymph nodes by using reverse transcriptase-polymerase chain reaction for keratin 19 mRNA.

Kamiya M, Ichiki Y, Kamiya H, Yamamoto A, Kitajima Y.

Br J Dermatol. 2003 Nov;149(5):998-1005.

PMID:
14632805
15.

Gene expression profiling of primary cutaneous melanoma and clinical outcome.

Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A; Melanoma Group of the European Organization for Research and Treatment of Cancer.

J Natl Cancer Inst. 2006 Apr 5;98(7):472-82.

PMID:
16595783
16.

Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.

Gimbergues P, Dauplat MM, Cayre A, Durando X, Le Bouedec G, Finat-Duclos F, Portefaix G, Kwiatkowski F, Dauplat J, Penault-Llorca F, Tchirkov A.

Eur J Surg Oncol. 2007 Feb;33(1):16-22. Epub 2006 Oct 27.

PMID:
17071045
17.

Melanoma gene expression and clinical course.

Vourc'h-Jourdain M, Volteau C, Nguyen JM, Khammari A, Dreno B.

Arch Dermatol Res. 2009 Oct;301(9):673-9. doi: 10.1007/s00403-009-0944-8. Epub 2009 Mar 27.

PMID:
19326132
18.

A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.

Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.

Gastroenterology. 2009 Jul;137(1):165-75. doi: 10.1053/j.gastro.2009.03.041. Epub 2009 Mar 26.

PMID:
19328798
19.

Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.

Manca G, Romanini A, Pellegrino D, Borsò E, Rondini M, Orlandini C, Zucchi V, Pasqualetti F, Mariani G.

J Nucl Med. 2008 Nov;49(11):1769-75. doi: 10.2967/jnumed.108.055350. Epub 2008 Oct 16.

20.

RT in situ PCR detection of MART-1 and TRP-2 mRNA in formalin-fixed, paraffin-embedded tissues of melanoma and nevi.

Itakura E, Huang RR, Wen DR, Paul E, Wünsch PH, Cochran AJ.

Mod Pathol. 2008 Mar;21(3):326-33. doi: 10.1038/modpathol.3801008. Epub 2008 Jan 18.

Supplemental Content

Support Center